Biology Behind Targeted Therapy for Lymphomas

Loading...

609 views
Loading...
Alert icon
Alert icon
Loading...
There is no Interactive Transcript.

Published on Mar 30, 2012 by

Louis Staudt, M.D., Ph.D., discusses the basic biology of targeted therapy for Diffuse B-cell Lymphoma. Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma. More info: http://j.mp/HffUy7

Category:

Science & Technology

License:

Creative Commons Attribution license (reuse allowed)

  • likes, 0 dislikes

All Comments (0) see all

Sign In or Sign Up now to post a comment!
  • Loading comment...
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more
    to add this to a playlist